Moderna gets $50M investment for Ebola vaccine candidate
Global health foundation Coalition for Epidemic Preparedness Innovations (CEPI) will invest $50 million to support development and initial clinical testing of Moderna's investigational vaccine against the Bundibugyo strain of Ebola, the deadly virus ripping through parts of the Democratic Republic of Congo. If early data are positive, the funding would also support manufacturing and progression to later-stage...
Global health foundation Coalition for Epidemic Preparedness Innovations (CEPI) will invest $50 million to support development and initial clinical testing of Moderna's investigational vaccine against the Bundibugyo strain of Ebola, the deadly virus ripping through parts of the Democratic Republic of Congo. If early data are positive, the funding would also support manufacturing and progression to later-stage...
Summary aggregated from The Hill's public RSS feed. The full reporting belongs to The Hill — please read it on their site.